Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7556
+0.0220 (3.00%)
At close: Aug 14, 2026, 4:00 PM EDT
0.6801
-0.0755 (-9.99%)
After-hours: Aug 14, 2026, 7:58 PM EDT
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$243,974
Profits / Employee
-$2,008,743
Market Cap
20.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 23 | 0 | - |
| Sep 30, 2024 | 23 | 1 | 4.55% |
| Sep 30, 2023 | 22 | 1 | 4.76% |
| Sep 30, 2022 | 21 | 6 | 40.00% |
| Sep 30, 2021 | 15 | 5 | 50.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Palatin Technologies | 29 |
| ABVC BioPharma | 19 |
| Quantum BioPharma | 17 |
| Werewolf Therapeutics | 14 |
| Cellectar Biosciences | 11 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
CTXR News
- 10 hours ago - Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 10 hours ago - Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 19 hours ago - Citius Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 19 hours ago - Citius Pharmaceuticals Earnings release: Q3 2026 - Filings
- 2 days ago - Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri - PRNewsWire
- 9 days ago - Citius Oncology reports availability of Lymphir in institutions grew 78% in Q3 - TheFly
- 9 days ago - Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment - PRNewsWire
- 24 days ago - Citius Oncology provides update on commercial launch of Lymphir - TheFly